Table 4.
Covariate | Patients |
|||
---|---|---|---|---|
All (n = 154) |
Resected (n = 116) |
|||
HR *(95% CI) | P | HR †(95% CI) | P | |
MRP2 G40A | ||||
AG/AA | reference | reference | ||
GG | 1.48 (0.97-2.27) | .068 | 1.99 (1.15-3.45) | .015 |
MRP5 A-2G | ||||
AG/GG | reference | reference | ||
AA | 1.56 (1.05-2.34) | .029 | 1.88 (1.16-3.06) | .011 |
HR was adjusted for history of diabetes, tumor size, serum level of CA19-9, tumor response, tumor resection, and genotype.
HR was adjusted for history of diabetes, tumor size, serum level of CA19-9, tumor response, and genotype.